Abstract:Objective: Wolcott–Rallison syndrome is a rare autosomal recessive inheritance disorder caused by the defectiveness of eukaryotic translation initiation factor 2 alpha kinase 3 (EIF2AK3), which encodes the PKR-like endoplasmic reticulum kinase (PERK). Defect in EIF2AK3 results in a permanent diabetes in early infancy or newborn period, a tendency to develop skeletal fractures and other associated disorders such as severe liver and renal dysfunction, and central hypothyroidism. Two patients with Wolcott–Rallison syndrome-like manifestations in a Chinese family and family members were genetically analyzed to identify if any variations that occurred in EIF2AK3, which may cause Wolcott–Rallison syndrome.Methods: Whole-exome sequencing (WES) was performed to identify genetic variations, and Sanger sequencing was conducted to verify the identified variations in the family members with Wolcott–Rallison syndrome (WRS) clinical manifestations. Several bioinformatics tools were employed to predict the effect of EIF2AK3 variations on the protein function. The impact on PERK protein was analyzed by sequential analysis and evolution conservation study.Results: Two novel EIF2AK3 heterozygous single base variations (c.2818C>T and c.2980G>C) were detected in the proband. PERK has two functional domains: one is regulatory domain (aa 1–576), and the other is catalytic domain (aa 577–1,115). Both variations are missense mutations and locate in catalytic domain of PERK; c.2818C>T resulted in a residue substitution of proline for serine at amino acid site 940 (p.Pro940Ser), and variation c.2980G>C caused an amino acid change at position 994 from glutamic acid to glutamine (p.Glu994Gln). These novel missense variations may affect the physiological functions of PERK protein.Conclusions: Two novel compound heterozygous EIF2AK3 variations (c.2818C>T, p.Pro940Ser and c.2980G>C, p.Glu994Gln) were found in a Chinese family. The identification of the variations and verification of their pathogenicity extended the variation spectrum of EIF2AK3 variations causing Wolcott–Rallison syndrome and enriched valuable information for precise medical intervention for Wolcott–Rallison syndrome in China.

Functional characterization of two DYRK1B variants causative of AOMS3

Two novel variants in DYRK1B causative of AOMS3: expanding the clinical spectrum

Novel Missense Variant in the TMEM151A Gene Causing Paroxysmal Kinesigenic Dyskinesia: a Case Report with Literature Review

Identification of Two Novel MYH3 Variants Causing Different Phenotypes in Prenatal Diagnosis.

A variant in detected in an individual with Knobloch type 2 syndrome

A mild skeletal phenotype with overlapping features of Miller syndrome and functional characterisation of two new variants of human dihydroorotate dehydrogenase

Identification and functional analysis of two new de novo KCNMA1 variants associated with Liang–Wang syndrome

Two Patients with KDM3B Variants and New Presentations of Diets–Jongmans Syndrome

Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice

Recessive variants in MYO1C as a potential novel cause of proteinuric kidney disease

Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes

Identification of two novel arylsulfatase A mutations with a polymorphism as a cause of metachromatic leukodystrophy

Homozygous XYLT2 variants as a cause of spondyloocular syndrome.

Understanding the Multifaceted Role of Human Down Syndrome Kinase DYRK1A

DYRK1A kinase triplication is the major cause of Otitis Media in Down Syndrome

De novo retinoic acid receptor beta (RARB) variant associated with microphthalmia and dystonia

Skeletal health in DYRK1A syndrome

Identification of Two Novel Compound Heterozygous EIF2AK3 Mutations Underlying Wolcott–Rallison Syndrome in a Chinese Family

Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

Rare Missense Variants in KCNJ10 Are Associated with Paroxysmal Kinesigenic Dyskinesia

DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis